The savings from shuttering USAID aren't worth the global costs
I recently returned from Ethiopia, where I help to lead a program that has trained essentially all of the pulmonary physicians in that country. During my visit, I spoke at the annual scientific meeting of the Ethiopian Thoracic Society. I have attended that meeting many times; every year there is also a presentation from the leader of the USAID-supported Ethiopian national tuberculosis control program.
Just recently, in fact, USAID announced a major new initiative to control and prevent tuberculosis (including drug-resistant tuberculosis) in Ethiopia, which is classified by the World Health Organization as a high-burden country for tuberculosis.
This year, there was no representative from USAID at the meeting to discuss the tuberculosis situation in Ethiopia or plans to combat the disease. My colleagues in Ethiopia who had organized the meeting told me that their emails and phone calls to their USAID colleagues had gone unanswered.
This of course occurred in the wake of the recent decision in Washington to shutter the agency. Despite assurances that support of vital programs in areas such as AIDS, malaria and tuberculosis would continue, this does not appear to be the case.
Ethiopia is a very poor country and the largest recipient of USAID funds in sub-Saharan Africa, at roughly $1 billion annually, a mere 0.015 percent of the annual U.S. budget. A great deal of that money goes to food aid, but significant funds support efforts in disease control and public health. The consequences of withdrawing support for activities such as the national tuberculosis program could be devastating.
In recent years Ethiopia, with USAID support, has made significant strides in adopting modern tuberculosis diagnostics and in providing new and more effective regimens to patients with drug-resistant tuberculosis. What will happen without continued support of that program? Patients will go longer before their tuberculosis is diagnosed. Their lungs will be more extensively damaged, so that even after cure of their tuberculosis they will be left with life-long pulmonary impairment. Potentially most worrisome of all, rates of drug-resistant tuberculosis will likely rise.
Several years ago, I worked on a project to try to understand the epidemiology of drug-resistant tuberculosis in Kazakhstan, a country with an astoundingly high rate of that particular form of the disease. In fact, the highest rates of drug-resistant tuberculosis are today mostly found in Russia and the countries of the former Soviet Union.
I had a conversation with the physician who was then head of the national tuberculosis control program in Kazakhstan, and I asked him what the genesis of the problem was. He explained to me that at the time the Soviet Union collapsed, there was no money available for the public health authorities to purchase enough antibiotics to allow effective treatment of tuberculosis patients who had fallen ill and to sustain a functioning national tuberculosis program. Prescribing and administration of drugs became erratic and incomplete, which is a recipe for generating drug-resistance.
This was all true. Thousands of patients died from drug-resistant forms of tuberculosis, a disease that is usually quite curable. Thirty-five years later, the problem is still severe in those countries. Although better and more effective drugs and regimens are now available to treat drug-resistant tuberculosis, those drugs are more expensive than older drugs, and they require careful administration and monitoring.
Withdrawal of USAID support will severely threaten tuberculosis control efforts in Ethiopia and in many other countries around the world. Tuberculosis remains largely a disease of countries with limited resources, and aid from the U.S. has been critical making progress in many of those countries. Funds from USAID support the introduction of advanced diagnostic techniques and the purchase of adequate quantities of the safest, most effective drugs to treat all forms of the disease. And of course, as with all infectious diseases, the microorganisms that cause tuberculosis don't know anything about national boundaries.
Tuberculosis is an ancient disease that over centuries has claimed the lives of millions of people. The modern era of treatment began only in the middle of the 20th century, and now we are able to cure the vast, vast majority of patients with drugs that should be available to everyone, everywhere. Hermann Biggs, a pioneering physician in public health in New York in the early part of the 20th century, famously said, 'Public health is purchasable. Within natural limitations a community can determine its own death-rate.'
Withdrawing support for the diagnosis and treatment of malaria, HIV infection and tuberculosis will have predictable consequences. The amount of money that is saved by closing USAID will likely have very little impact in the U.S., but in the countries where that money was to have been spent, the consequences will be enormous and deadly.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
"Razor blade throat": The "Nimbus" COVID variant sparks concern of summer surge
Post-pandemic amnesia is a natural reaction, and it's common for misremembering to occur after a pandemic or collective traumatic event occurs. Yet the reality is that SARS-CoV-2, the virus causing COVID-19, is still finding ways to infect people by evolving new mutations, and a new variant has raised concern among virologists that continue to track the virus. Last month, the World Health Organization labeled the COVID variant NB.1.8.1 a 'variant under monitoring' because it has been surging across Asia and made up 10.7% of global sequences reported as of mid-May. Now, the variant has been detected in the United States, Europe and Canada as well, concerning virus trackers who — for the first time since the Pirola variant began circulating in August 2023 — bestowed upon it a nickname: Nimbus. Nimbus has recombined genetic material from other strains three times. Although the process of recombination is a natural process of viruses trying to evolve to survive among the population, recombination events are concerning because each time a virus does so, it has the potential to evolve into something that is more infectious or causes more severe disease. One of these mutations in Nimbus allows it to evade the immunity we have built against the virus from prior infections, so transmissibility might be slightly higher, said Dr. Rajendram Rajnarayanan, of the New York Institute of Technology campus in Jonesboro, Arkansas. A recent preprint study, not yet peer-reviewed, found that the way this variant binds to cells could make it infect them more efficiently than earlier strains and that it could be easier for this strain to be passed along to someone else. However, there has not been any evidence yet to suggest that Nimbus is linked to more severe illness. 'We haven't seen a big surge in emergency departments due to COVID-related conditions and respiratory things in this term yet,' Rajnarayanan told Salon in a video call. 'We have to wait and watch.' Recently, many people have been reporting a symptom called 'razor blade throat,' but it's unclear if this is a symptom of COVID or one of the many other viruses circulating. Overall, it is difficult to attribute certain symptoms to variants when there are more than a dozen circulating at a time and testing remains relatively low compared to earlier stages of the pandemic, said Dr. T. Ryan Gregory, an evolutionary and genome biologist at the University of Guelph in Canada. 'That said, we learned from Omicron that high transmissibility can cause as much damage as high per infection virulence, and at this point it is not just acute severity that is of concern, but longer-term impacts of repeated infection,' Gregory told Salon in an email. Such impacts include conditions like "long COVID," in which the symptoms of COVID last for months or years, often disabling current data shows that most COVID infections in the U.S. are currently caused by the LP.8.1 variant, which descends from Pirola. Both of these strains are technically still in the WHO's Greek letter 'Omicron' family, which now contains thousands of offspring. If there's one thing viruses are good at, it's mutating into new forms that can evade our immunity, whether that's from vaccines or past infections. In 2023, the WHO decided to only name variants with this system if they were considered a 'variant of concern' and stated that certain action steps should be taken by countries if a variant fell under this classification. However, the agency has not labeled any variants like this since Omicron. Some argue that some variants have been different enough to warrant a new name, and that not naming variants makes it more difficult to distinguish between the complex alphabet soup of variants that are circulating at any given time. For example, Pirola, which included the BA.2.86 variant along with its descendants, was about as genetically different from the original Omicron strain as Omicron was from the original 'wild strain' virus from Wuhan, China. Nevertheless, in the past two years, 'it's largely been the Pirola show,' Gregory said. Current vaccines have been designed to protect against this strain. So far, Nimbus is not very common in the U.S., but it has been identified in California and has enough mutations in its spike protein that it has a potential to cause waves of illness in other regions — which is in part why it was designated a name. At-home tests should still work to detect this variant, but PCR tests that doctors can order are more accurate. Masking also helps prevent the spread of the virus. Every year following the start of the COVID pandemic, cases have surged in the summer. Last year's summer surge hit around August and was so intense that vaccines were approved slightly early. Although this year's summer wave hasn't yet started, experts predict we will likely experience another wave this summer. As it stands, variant trackers expect either Nimbus or another variant called XFG to be the dominant strain this time around. Although XFG currently makes up a greater proportion of cases in North America than NB.1.8.1, the latter has been detected in New York and California. 'NB.1.8.1 is a strong candidate for the summer surge,' Rajnarayanan said. 'Yet what we know from previous instances is that it doesn't have to be a single variant that pushes up [to prominence] and sometimes it can be a group of variants … that pick up mutations from each other and recombine.' The good news is that Nimbus is still similar enough to the Pirola variants that the available vaccines were designed to target. That means they should still be effective, Gregory said. However, concerns have been raised that vaccine access may be limited this fall due to the Food and Drug Administration announcing it would require drugmakers to conduct a new set of clinical trials before approving new vaccines for use. Last month, the FDA also said it will only recommend COVID vaccines for adults 65 and older and those at risk for severe illness. Critics have said this will only make the vaccines less likely to be covered by insurance and less available overall. On Monday, secretary of the Department of Health and Human Services Robert F. Kennedy announced he was firing the expert panel that advises the Centers for Disease Control responsible for making recommendations on vaccines, further complicating matters. Paired with updated guidelines from the CDC that drop recommendations for healthy pregnant women and kids to routinely get vaccinated, these changes from the federal government could have a chilling effect that leads fewer people to get vaccinated. 'I'm concerned about accessibility,' Rajnarayanan said, adding that it's not clear if vaccines will be available to people without insurance that aren't included in federal recommendations. 'These kinds of things are still murky and I really want to see clearer guidelines.' While many people may seem to have forgotten about COVID, people are still routinely hospitalized and killed by the virus. Additionally, each COVID nfection carries a risk of going on to develop long Covid, which continues to debilitate millions of people. As we witnessed when COVID was a full-blown pandemic, emerging viruses can be especially damaging for people with existing conditions like diabetes, obesity and heart disease. It's important to protect against things like long COVID not only for the well-being of people today but also for our susceptibility to future viruses, Rajnarayanan said. 'In different parts of the world, I've seen funding for continuous surveillance gone down, and not just for surveillance, which is important, but also studying the disease itself,' Rajnarayanan said. 'This is not just about protecting [people] today but also protecting them from any other variant in the future.'
CNN
an hour ago
- CNN
US foreign aid cuts threaten decades of progress on driving down malaria
Cuts to US-funded malaria programs are adding to a host of issues confronting Congolese mother Mwayuma Idi Feza, whose city, Goma, is at the center of the country's intensifying conflict and run by a vicious militia. 'I have a child who is sick. He has had malaria for a week and a few days now,' Feza, 36, told CNN of her 1-year-old son, whose fever she suspects is caused by the mosquito-borne illness. She is also experiencing symptoms of the disease, she said. 'I'm feeling cold. I feel bitterness in my mouth.' The single mother is out of work and said she can barely afford food, much less malaria treatment for her and her baby. Malaria is a preventable and curable disease, but it still claims hundreds of thousands of lives around the world each year. Infants, children under five and pregnant women are most likely to die from a malaria infection. It's a leading cause of death in the Democratic Republic of Congo (DRC), which bears the world's second-highest malaria burden after Nigeria, according to the World Health Organization (WHO). In 2022, some 24,000 people were estimated to have died of the disease in the central African nation. More than half those deaths were of children under 5. Since the Trump administration started slashing foreign aid early this year, an estimated 36% of US Agency for International Development (USAID) funding for malaria programs has been cut, according to the Center for Global Development, a DC-based think tank. But the true level of aid cuts remains uncertain. In the DRC, that money funded the supply of antimalarials to 'many health zones' across the country, 'including intermittent preventive treatment for pregnant women,' according to Michel Itabu, a former spokesperson for the country's National Malaria Control Program (PNLP), referring to a WHO-recommended program in areas where malaria is endemic. 'The PNLP is already feeling the effects' of the funding cuts, Itabu told CNN. Such preventive programs might have protected Idi Feza and her baby son – instead, if infected, they are both at risk of serious illness or even death. The US government has long been the largest donor to global efforts to combat malaria. For decades, USAID spearheaded a program called the President's Malaria Initiative (PMI) to drive down mortality and eliminate malaria in 30 of the hardest-hit nations, most of which are in Africa. Launched by George W. Bush in 2005, the program helped reduce malaria deaths by more than 60% – saving millions of lives. CNN spoke to several people who previously worked on the initiative but were recently laid off amid Trump's dismantling of USAID. Most PMI staff have been let go or had their work halted by stop-work orders, and the Trump administration's proposed budget called for a 47% cut to the program. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security.' Former USAID contractor, speaking anonymously for fear of reprisals Every aid worker who spoke to CNN emphasized that people would die in the short term as a result of the disruption to malaria prevention and treatment efforts. Longer term, they said the funding cuts would destroy years of American progress in driving down the prevalence and severity of the disease. US-backed surveillance systems that were once the backbone of efforts to monitor malaria and other disease outbreaks around the world have also been cut, former US government workers told CNN, underscoring long-term concerns. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security,' one former USAID contractor told CNN in February, speaking anonymously for fear of reprisals. She warned that locally acquired malaria cases, like Florida experienced in 2023, could become more common 'if we're not funding driving down the parasite elsewhere.' Aid workers and nonprofits have repeatedly made the case that malaria programs and US disease monitoring make America 'safer, stronger and more prosperous,' which was Secretary of State Marco Rubio's stated framework for assessing US foreign assistance. For example, USAID and the US military have long invested in malaria vaccine research to both reduce the global disease burden and protect US soldiers serving abroad. Spencer Knoll, US policy and advocacy director at the nonprofit Malaria No More, said in testimony to the US House Appropriations Subcommittee in April that 'the world's most dangerous infectious diseases – including Ebola, Marburg, and pandemic influenza – often present first as fevers, and malaria detection programs can stop outbreaks in their tracks.' The nonprofit also argued that US assistance prevents other countries like China and Iran from making further inroads in Africa in terms of soft power. 'Everything that comes from USAID… was very intentionally branded, with this logo that says 'from the American people.' People know where it was coming from,' said former PMI contractor Annē Linn, who lost her job in January. 'When all of a sudden everything stops, that just tears down trust – not just from our government to other governments, but within countries' own health systems.' Between 2010 and 2023, the US contributed more than one-third of the world's malaria financing, according to WHO. As of last year, the US was also the largest contributor to the Global Fund, which works to fight AIDS, tuberculosis and malaria. It's unclear what the future level of US funding for the independent, public-private program will be, following the Trump administration's proposal to halve US matching contributions. The Trump administration's funding cuts 'could reverse decades of progress earned, in part, through longstanding investments from the United States of America and other global partners,' WHO warned in a statement earlier this year. 'Although funding for some USA-supported malaria programs have been reinstated, the disruptions have left critical gaps.' The US State Department did not respond to questions from CNN about the stop-work orders and where specifically budget cuts to the PMI would be felt. Former aid workers emphasized concerns about lack of investment to tackle several global threats related to malaria, including drug resistance, increasingly insecticide-resistant mosquitoes and new, invasive types of mosquitoes that are moving into urban areas with high populations. 'The timing for all of this couldn't be worse. Malaria is seasonal, and so having interruptions during times of seasonality sets us back significantly,' said Nathaniel Moller, formerly a senior innovation adviser at the PMI, whose job was cut in January. He warned that with less funding for measures like bed nets and preventative medicine, the baseline of cases will rise this year, enabling further spread of the disease down the road. 'You missed that window, and you can't just go back to that initial baseline… it's going to go up,' Moller said, noting that the rainy season is already underway in parts of east, central and southern Africa. 'We risk losing years of investments and seeing the caseload increase significantly.' That bad timing is particularly evident in Malawi, where recent flooding and cyclones have driven up malaria infections, the country's National Malaria Control Manager Lumbani Munthali told CNN. He added that cuts to USAID funding for malaria interventions have put the country in 'a difficult situation' because 'it's not easy to close the gaps that have been created.' More than 2,000 people died of malaria in Malawi last year. Some 9 million were infected. 'Malawi has made significant progress in reducing malaria deaths because of the technical and financial support from the US government,' Munthali said. That funding went towards procuring millions of malaria tests kits annually and providing insecticide-treated bed nets and antimalarial medication for pregnant women and nursing mothers. 'We are trying to close those gaps but may not close them completely,' Munthali said, as Malawi adjusts to the sharp drop-off in US foreign aid. About 64% of Malawi's USAID funding has been cut across all programs, according to the Center for Global Development's analysis. In 2023, the most recent year for which PMI figures are available, Malawi received $24 million for its fight against malaria. It's not yet clear exactly how much it will lose this year, Munthali said. Cuts to other areas of US foreign aid, like malnutrition programs, will have overlapping effects in Africa, aid workers also warned. 'Kids that are acutely malnourished will be more vulnerable to other diseases,' like measles, cholera and malaria, according to Nicolas Mouly, an emergency coordinator for Doctors Without Borders, or Médecins Sans Frontières (MSF), who works in northwest Nigeria. He said funding gaps for malnutrition programs that were already present in 2024 have deepened significantly this year. Malaria infection can also lead to malnutrition, fueling what MSF has called 'a vicious cycle.' Nigeria's health minister, Muhammad Ali Pate, told CNN that the government has mobilized domestic funding for its health sector, including $200 million recently approved by parliament to lessen the effects of losing USAID funding. 'When the change in US government occurred and the policy was made, we considered it as another opportunity for reset and for us to increase our domestic funding so that we can meet the responsibility of the health of our population,' he said. 'At the end of the day, the responsibility of the health of Nigerians is on the Nigerian government. It is never a primary responsibility of the US government.' MSF doesn't rely on US government funding, but the organization said its programs have been burdened with additional patients following US cuts to other humanitarian actors in the region. 'We won't have the capacity to treat all of them,' Mouly said. Aid organizations prepare for the annual peak of malnutrition – when fall harvests have yet to arrive and rainy seasons have increased malaria cases – by stockpiling ready-to-use therapeutic food sachets. But for this year's lean season, Mouly said there is 'uncertainty' about their availability. 'We can expect a very critical situation,' Mouly said, emphasizing that children will die as a result. 'We've not seen anything like this in terms of disruption of global aid. It's very difficult.' Lauren Kent reported and wrote from London. Nimi Princewill reported from Abuja, Nigeria.
CNN
2 hours ago
- CNN
US foreign aid cuts threaten decades of progress on driving down malaria
Cuts to US-funded malaria programs are adding to a host of issues confronting Congolese mother Mwayuma Idi Feza, whose city, Goma, is at the center of the country's intensifying conflict and run by a vicious militia. 'I have a child who is sick. He has had malaria for a week and a few days now,' Feza, 36, told CNN of her 1-year-old son, whose fever she suspects is caused by the mosquito-borne illness. She is also experiencing symptoms of the disease, she said. 'I'm feeling cold. I feel bitterness in my mouth.' The single mother is out of work and said she can barely afford food, much less malaria treatment for her and her baby. Malaria is a preventable and curable disease, but it still claims hundreds of thousands of lives around the world each year. Infants, children under five and pregnant women are most likely to die from a malaria infection. It's a leading cause of death in the Democratic Republic of Congo (DRC), which bears the world's second-highest malaria burden after Nigeria, according to the World Health Organization (WHO). In 2022, some 24,000 people were estimated to have died of the disease in the central African nation. More than half those deaths were of children under 5. Since the Trump administration started slashing foreign aid early this year, an estimated 36% of US Agency for International Development (USAID) funding for malaria programs has been cut, according to the Center for Global Development, a DC-based think tank. But the true level of aid cuts remains uncertain. In the DRC, that money funded the supply of antimalarials to 'many health zones' across the country, 'including intermittent preventive treatment for pregnant women,' according to Michel Itabu, a former spokesperson for the country's National Malaria Control Program (PNLP), referring to a WHO-recommended program in areas where malaria is endemic. 'The PNLP is already feeling the effects' of the funding cuts, Itabu told CNN. Such preventive programs might have protected Idi Feza and her baby son – instead, if infected, they are both at risk of serious illness or even death. The US government has long been the largest donor to global efforts to combat malaria. For decades, USAID spearheaded a program called the President's Malaria Initiative (PMI) to drive down mortality and eliminate malaria in 30 of the hardest-hit nations, most of which are in Africa. Launched by George W. Bush in 2005, the program helped reduce malaria deaths by more than 60% – saving millions of lives. CNN spoke to several people who previously worked on the initiative but were recently laid off amid Trump's dismantling of USAID. Most PMI staff have been let go or had their work halted by stop-work orders, and the Trump administration's proposed budget called for a 47% cut to the program. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security.' Former USAID contractor, speaking anonymously for fear of reprisals Every aid worker who spoke to CNN emphasized that people would die in the short term as a result of the disruption to malaria prevention and treatment efforts. Longer term, they said the funding cuts would destroy years of American progress in driving down the prevalence and severity of the disease. US-backed surveillance systems that were once the backbone of efforts to monitor malaria and other disease outbreaks around the world have also been cut, former US government workers told CNN, underscoring long-term concerns. 'One of the reasons that we don't have malaria in the US is because we fund and track malaria worldwide, for global health security,' one former USAID contractor told CNN in February, speaking anonymously for fear of reprisals. She warned that locally acquired malaria cases, like Florida experienced in 2023, could become more common 'if we're not funding driving down the parasite elsewhere.' Aid workers and nonprofits have repeatedly made the case that malaria programs and US disease monitoring make America 'safer, stronger and more prosperous,' which was Secretary of State Marco Rubio's stated framework for assessing US foreign assistance. For example, USAID and the US military have long invested in malaria vaccine research to both reduce the global disease burden and protect US soldiers serving abroad. Spencer Knoll, US policy and advocacy director at the nonprofit Malaria No More, said in testimony to the US House Appropriations Subcommittee in April that 'the world's most dangerous infectious diseases – including Ebola, Marburg, and pandemic influenza – often present first as fevers, and malaria detection programs can stop outbreaks in their tracks.' The nonprofit also argued that US assistance prevents other countries like China and Iran from making further inroads in Africa in terms of soft power. 'Everything that comes from USAID… was very intentionally branded, with this logo that says 'from the American people.' People know where it was coming from,' said former PMI contractor Annē Linn, who lost her job in January. 'When all of a sudden everything stops, that just tears down trust – not just from our government to other governments, but within countries' own health systems.' Between 2010 and 2023, the US contributed more than one-third of the world's malaria financing, according to WHO. As of last year, the US was also the largest contributor to the Global Fund, which works to fight AIDS, tuberculosis and malaria. It's unclear what the future level of US funding for the independent, public-private program will be, following the Trump administration's proposal to halve US matching contributions. The Trump administration's funding cuts 'could reverse decades of progress earned, in part, through longstanding investments from the United States of America and other global partners,' WHO warned in a statement earlier this year. 'Although funding for some USA-supported malaria programs have been reinstated, the disruptions have left critical gaps.' The US State Department did not respond to questions from CNN about the stop-work orders and where specifically budget cuts to the PMI would be felt. Former aid workers emphasized concerns about lack of investment to tackle several global threats related to malaria, including drug resistance, increasingly insecticide-resistant mosquitoes and new, invasive types of mosquitoes that are moving into urban areas with high populations. 'The timing for all of this couldn't be worse. Malaria is seasonal, and so having interruptions during times of seasonality sets us back significantly,' said Nathaniel Moller, formerly a senior innovation adviser at the PMI, whose job was cut in January. He warned that with less funding for measures like bed nets and preventative medicine, the baseline of cases will rise this year, enabling further spread of the disease down the road. 'You missed that window, and you can't just go back to that initial baseline… it's going to go up,' Moller said, noting that the rainy season is already underway in parts of east, central and southern Africa. 'We risk losing years of investments and seeing the caseload increase significantly.' That bad timing is particularly evident in Malawi, where recent flooding and cyclones have driven up malaria infections, the country's National Malaria Control Manager Lumbani Munthali told CNN. He added that cuts to USAID funding for malaria interventions have put the country in 'a difficult situation' because 'it's not easy to close the gaps that have been created.' More than 2,000 people died of malaria in Malawi last year. Some 9 million were infected. 'Malawi has made significant progress in reducing malaria deaths because of the technical and financial support from the US government,' Munthali said. That funding went towards procuring millions of malaria tests kits annually and providing insecticide-treated bed nets and antimalarial medication for pregnant women and nursing mothers. 'We are trying to close those gaps but may not close them completely,' Munthali said, as Malawi adjusts to the sharp drop-off in US foreign aid. About 64% of Malawi's USAID funding has been cut across all programs, according to the Center for Global Development's analysis. In 2023, the most recent year for which PMI figures are available, Malawi received $24 million for its fight against malaria. It's not yet clear exactly how much it will lose this year, Munthali said. Cuts to other areas of US foreign aid, like malnutrition programs, will have overlapping effects in Africa, aid workers also warned. 'Kids that are acutely malnourished will be more vulnerable to other diseases,' like measles, cholera and malaria, according to Nicolas Mouly, an emergency coordinator for Doctors Without Borders, or Médecins Sans Frontières (MSF), who works in northwest Nigeria. He said funding gaps for malnutrition programs that were already present in 2024 have deepened significantly this year. Malaria infection can also lead to malnutrition, fueling what MSF has called 'a vicious cycle.' Nigeria's health minister, Muhammad Ali Pate, told CNN that the government has mobilized domestic funding for its health sector, including $200 million recently approved by parliament to lessen the effects of losing USAID funding. 'When the change in US government occurred and the policy was made, we considered it as another opportunity for reset and for us to increase our domestic funding so that we can meet the responsibility of the health of our population,' he said. 'At the end of the day, the responsibility of the health of Nigerians is on the Nigerian government. It is never a primary responsibility of the US government.' MSF doesn't rely on US government funding, but the organization said its programs have been burdened with additional patients following US cuts to other humanitarian actors in the region. 'We won't have the capacity to treat all of them,' Mouly said. Aid organizations prepare for the annual peak of malnutrition – when fall harvests have yet to arrive and rainy seasons have increased malaria cases – by stockpiling ready-to-use therapeutic food sachets. But for this year's lean season, Mouly said there is 'uncertainty' about their availability. 'We can expect a very critical situation,' Mouly said, emphasizing that children will die as a result. 'We've not seen anything like this in terms of disruption of global aid. It's very difficult.' Lauren Kent reported and wrote from London. Nimi Princewill reported from Abuja, Nigeria.
